Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HDHD2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | TRIM65 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | RMI1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | FEM1A | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | MPHOSPH9 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | SUPT16H | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | WHSC1L1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | KRI1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | CEP295NL | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | RPL5 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |